Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  human papillomavirus 16/18 L1 virus-like particle/AS04 vaccine
Find trials that include:  Any drugs shown
Trial Status:  Active
Results 1-7 of 7 for your search:
Start Over
Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females
Phase: Phase IV
Type: Prevention
Status: Active
Age: 15 to 25
Sponsor: Pharmaceutical / Industry
Protocol IDs: 109823, 2013-003429-28, NCT01031069
Evaluation of Long Term Immunity Following HPV Vaccination
Phase: Phase III, Phase II
Type: Natural history/Epidemiology
Status: Active
Age: 15 to 17
Sponsor: Other
Protocol IDs: 2014.5.FNRERC.5.SU, NCT02276521
Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study
Phase: Phase III
Type: Prevention
Status: Active
Age: 26 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 113621, NCT01190189
The Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study
Phase: Phase III
Type: Prevention
Status: Active
Age: 26 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 113618, NCT01249365
Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus Vaccine in Healthy Female Children
Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 4 to 6 and 15 to 25
Sponsor: Pharmaceutical / Industry
Protocol IDs: 115887, 2011-005604-15, NCT01627561
Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer
Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UbiVac DPV-001, R44CA121612, NCT01909752
Pilot Study of DRibble Vaccine for Prostate Cancer Patients
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Not specified
Sponsor: Pharmaceutical / Industry
Protocol IDs: 14-116B, NCT02234921
Start Over